GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-04-26 7:31:39 PM | Chg. +0.092 | Volume | Bid7:31:42 PM | Ask7:31:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.240EUR | +1.13% | 0 Turnover: 0.000 |
8.242Bid Size: 320 | 8.392Ask Size: 320 | 6.92 bill.EUR | - | 93.18 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...